| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | — |
| Cost of Revenue | $181K | — |
| Gross Profit | $1.2M | — |
| R&D Expense | $1.3M | -45.2% |
| SG&A Expense | $105K | -88.9% |
| Operating Income | -$13.0M | -29.7% |
| Pre-tax Income | -$12.3M | -12.9% |
| Income Tax | $0 | — |
| Net Income | -$11.9M | -9.6% |
| EPS (Basic) | -$2.81 | +50.3% |
| EPS (Diluted) | -$2.81 | +50.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $677K | — |
| Current Assets | $7.4M | +599.2% |
| Total Assets | $16.2M | +81.3% |
| Current Liabilities | $1.8M | -60.8% |
| Long-term Debt | $150K | +0.0% |
| Total Liabilities | $2.1M | -58.6% |
| Stockholders' Equity | $13.6M | +325.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.6M | -29.4% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $13.7M | +140.6% |